Depression in chronic heart failure: Complication, risk factor or autonomous disease?;Depression bei herzinsuffizienz. Komplikation, risikofaktor oder eigene erkrankung?

Internist

Volumn 49, Issue 4, 2008, Pages 394-404

  Faller, H ^a   Angermann, C E ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Chronic heart failure; Depression; Psychotherapy; Serotonin re uptake inhibitors

Indexed keywords

ESCITALOPRAM; SEROTONIN UPTAKE INHIBITOR;

CHRONIC DISEASE; CLINICAL TRIAL; COMORBIDITY; DEPRESSION; DISEASE SEVERITY; GENETIC PREDISPOSITION; HEALTH BEHAVIOR; HEART FAILURE; HUMAN; IMMUNOPATHOLOGY; ISCHEMIC HEART DISEASE; MAJOR DEPRESSION; MENTAL STRESS; PATHOPHYSIOLOGY; PATIENT COMPLIANCE; PREVALENCE; PROGNOSIS; PSYCHOTHERAPY; REVIEW; RISK FACTOR; SOCIAL ENVIRONMENT;

EID: 41149146928     PISSN: 00209554     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00108-008-2048-5     Document Type: Review

References (40)

1. Angermann CE, Gelbrich G, Störk S et al. (2007) Rationale and design of a randomized, controlled multicenter trial investigating the effects of selective serotonin re-uptake inhibition on morbidity, mortality and mood in depressed heart failure patients (MOOD-HF). Eur J Heart Fail 9: 1212-1222
2. Angermann CE, Gelbrich G, Störk S et al. on behalf of the German Competence Network for Heart Failure (2008) Prevalence and predictors of depression in patients with systolic heart failure. Risk factors and protective principles. (in progress)
3. Bagby RM, Ryder AG, Schuller DR et al. (2004) The Hamilton Depression Rating Scale: has the gold standard become a lead weight? Am J Psychiatry 161: 2163-2177
4. Bane C, Hughes CM, McElnay JC (2006) The impact of depressive symptoms and psychosocial factors on medication adherence in cardiovascular disease. Patient Educ Couns 60: 187-193
5. Berkman LF, Blumenthal J, Burg M et al. (2003) Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial. JAMA 289: 3106-3116
6. Bullinger M, Kirchberger I (1998) SF-36 Fragebogen zum Gesundheitszustand. Hogrefe, Göttingen
7. Carney RM, Blumenthal JA, Freedland KE et al. (2004) Depression and late mortality after myocardial infarction in the Enhancing Recovery in Coronary Heart Disease (ENRICHD) study. Psychosom Med 66: 466-474
8. Faller H, Steinbüchel S, Schowalter M et al. (2005) Der Kansas City Cardiomyopathy Questionnaire (KCCQ) - ein neues krankheitsspezifisches Messinstrument zur Erfassung der Lebensqualität bei chronischer Herzinsuffizienz. Psychometrische Prüfung der deutschen Version. Psychother Psych Med 55: 200-208
9. Faller H, Störk S, Schowalter M et al. (2007) Depression and survival in chronic heart failure: Does gender play a role? Eur J Heart Fail 9: 1018-1023
10. Faller H, Störk S, Schowalter M et al. (2007) Is patients' health related quality of life an independent predictor of survival in chronic heart failure? J Psychosom Res 63: 533-538
11. Frasure-Smith N, Lespérance F, Irwin MR et al. (2007) Depression, C-reactive protein and two-year major adverse cardiac events in men after acute coronary syndromes. Biol Psychiatry 62: 302-308
12. Freedland KE, Rich MW, Skala JA et al. (2003) Prevalence of depression in hospitalized patients with congestive heart failure. Psychosom Med 65: 119-128
13. Friedmann E, Thomas SA, Liu F et al. (2006) Relationship of depression, anxiety, and social isolation to chronic heart failure outpatient mortality. Am Heart J 940: 1-8
14. Glassman AH, O'Connor CM, Califf RM et al. (2002) Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA 288: 701-709
15. Grippo AJ, Johnson AK (2002) Biological mechanisms in the relationship between depression and heart disease. Neurosci Biobehav Rev 26: 941-962
16. Haworth JE, Moniz-Cook E, Clark AL et al. (2005) Prevalence and predictors of anxiety and depression in a sample of chronic heart failure patients with left ventricular systolic dysfunction. Eur J Heart Fail 7: 803-808
17. Jacobi F, Wittchen H-U, Hölting C et al. (2004) Prevalence, co-morbidity and correlates of mental disorders in the general population: results from the German Health Interview and Examination Survey (GHS). Psychol Med 34: 597-611
18. Jiang W, Kuchibhatla M, Clary GL et al. (2007) Relationship between depressive symptoms and long-term mortality in patients with heart failure. Am Heart J 154: 102-108
19. Jonge P de, Honig A, Melle JP van et al. (2007) Nonresponse to treatment for depression following myocardial infarction: Association with subsequent cardiac events. Am J Psychiatry 164: 1371-1378
20. Kop WJ, Gottdiener JS (2005) The role of immune system parameters in the relationship between depression and coronary artery disease. Psychosom Med (Suppl 1) 67: 37-41
21. Lespérance F, Frasure-Smith N, Koszycki D et al. (2007) Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease. The Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) Trial. JAMA 297: 367-379
22. Lett HS, Blumenthal JA, Babyak MA et al. (2005) Social support and coronary heart disease: epidemiologic evidence and implications for treatment. Psychosom Med 67: 869-878
23. Löwe B, Gräfe K, Zipfel S et al. (2004) Diagnosing ICD-10 depressive episodes: Superior criterion validity of the Patient Health Questionnaire. Psychother Psychosom 73: 386-390
24. Löwe B, Kroenke K, Gräfe K (2005) Detecting and monitoring depression with a two-item questionnaire (PHQ-2). J Psychosom Res 58: 163-171
25. McCaffery JM, Frasure-Smith N, Dubé MP et al. (2006) Common genetic vulnerability to depressive symptoms and coronary artery disease: a review and development of candidate genes related to inflammation and serotonin. Psychosom Med 68: 187-200
26. Melle JP van, Jonge P de, Honig A et al. (2007) Effects of antidepressant treatment following myocardial infarction. Br J Psychiatry 190: 460-466
27. Nakatani D, Sato H, Sakata Y et al. (2005) Influence of serotonin transporter gene polymorphism on depressive symptoms and new cardiac events after acute myocardial infarction. Am Heart J 150: 652-658
28. Otte C, McCaffery J, Ali S et al. (2007) Association of a serotonin transporter polymorphism (5-HTTLPR) with depression, perceived stress, and norepinephrine in patients with coronary disease: The Heart and Soul study. Am J Psychiatry 164: 1379-1384
29. Pasic J, Levy WC, Sullivan MD (2003) Cytokines in depression and heart failure. Psychosom Med 65: 181-193
30. Rozanski A, Blumenthal JA, Davidson KW et al. (2005) The epidemiology, pathophysiology, and management of psychosocial risk factors in cardiac practice. J Am Coll Cardiol 45: 637-651
31. Rutledge T, Reis VA, Linke SE et al. (2006) Depression in heart failure. A meta-analytic review of prevalence, intervention effects, and associations with clinical outcomes. J Am Coll Cardiol 48: 1527-1537
32. Scherrer JF, Xian H, Bucholz KK et al. (2003) A twin study of depression symptoms, hypertension, and heart disease in middle-aged men. Psychosom Med 65: 548-557
33. Serebruany VL, Glassman AH, Malinin AI et al. (2003) Selective serotonin reuptake inhibitors yield additional antiplatet protection in patients with congestive heart failure treated with antecedent aspirin. Eur J Heart Fail 5: 517-521
34. Sherwood A, Blumenthal JA, Trivedi R et al. (2007) Relationship of depression to death or hospitalization in patient with heart failure. Arch Intern Med 167: 367-373
35. Shimbo D, Davidson KW, Haas DC et al. (2005) Negative impact of depression on outcomes in patients with coronary artery disease: Mechanisms, treatment considerations, and future directions. J Thromb Haemost 3: 897-908
36. Smith W, Ruiz JM (2002) Psychosocial influences on the development and course of coronary heart disease: current status and implications for research and practice. J Consult Clin Psychol 70: 548-568
37. Spitzer RL, Kroenke K, Williams JB et al. (2006) A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med 166: 1092-1097
38. Sullivan M, Simon G, Spertus J et al. (2002) Depression-related costs in heart failure care. Arch Intern Med 162: 1860-1866
39. Taylor CB, Youngblood ME, Catellier D et al. (2005) Effects of antidepressant medication on morbidity and mortality in depressed patients after myocardial infarction. Arch Gen Psychiatry 62: 792-798
40. Vogels RL, Scheltens P, Schroeder-Tanka JM et al. (2007) Cognitive impairment in heart failure: a systematic review of the literature. Eur J Heart Fail 9: 440-449